Abstract:TGF-β is a pivotal cytokine that orchestrates various aspects of cancer progression, including tumor growth, metastasis, and immune evasion. In this review, we present a comprehensive overview of the multifaceted role of transforming growth factor β (TGF-β) in cancer biology, focusing on its intricate interactions with monocytes and macrophages within the tumor microenvironment (TME). We specifically discuss how TGF-β modulates monocyte and macrophage activities, leading to immunosuppression and tumor progression. We conclude with the current translational and clinical efforts targeting TGF-β, recognizing the promising role of this strategy in immunooncology. Transforming growth factor β (TGF-β), a pivotal cytokine, plays a crucial role in maintaining homeostasis and influencing cancer development by affecting various cell types. In cancer, TGF-β initially suppresses tumor cell growth but later contributes to tumor progression and metastasis, presenting challenges in developing therapeutics targeting this cytokine. Mechanistically, TGF-β impacts diverse cellular processes through canonical Smad and non-Smad pathways, that explains its diverse regulation of different, sometimes opposing, cellular processes. In the context of immunity, exposure to TGF-β renders immune cells immunosuppressive, hindering their ability to fight tumor development. This article explores the effects of TGF-β on monocytes and macrophages, highlighting its role in creating an immunosuppressive tumor microenvironment (TME) required for tumor survival and growth. The article provides an update on recent studies that underscore the potential of TGF-β inhibition in modulating the immune response within the TME, thereby enhancing the effectiveness of cancer immunotherapy. Overall, this review article delves into the multifaceted role of TGF-β in cancer biology, with a specific focus on its interactions with monocytes and macrophages. It underscores the knowledge gaps and the importance of targeting TGF-β signaling in tumor-associated monocytes and macrophages as a promising therapeutic approach in TGF-β secreting tumors.

Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting

TGF-beta and Immune Cells: an Important Regulatory Axis in the Tumor Microenvironment and Progression.

Targeting TGFβ signal transduction for cancer therapy

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy

Overcoming TGFβ-mediated immune evasion in cancer

TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma

Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

TGF-β-Regulated MicroRNAs and Their Function in Cancer Biology.

The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment

Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target

Therapeutic Targeting Of Tgf-Beta In Cancer: Hacking A Master Switch Of Immune Suppression

Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

Therapeutic Targeting of TGF-β in Cancer: Hacking a Master Switch of Immune Suppression.

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis

Targeting cytokine and chemokine signaling pathways for cancer therapy

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention

Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils

On-Target Anti-TGF- Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?

Managing the TME to improve the efficacy of cancer therapy